tiprankstipranks
Veradigm (MDRX)
OTHER OTC:MDRX
Holding MDRX?
Track your performance easily

Veradigm (MDRX) Technical Analysis

215 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Veradigm’s (MDRX) Moving Averages Convergence Divergence (MACD) indicator is -0.16, suggesting Veradigm is a Buy.
Veradigm’s (MDRX) 20-Day exponential moving average is 10.09, while Veradigm’s (MDRX) share price is $9.5, making it a Sell.
Veradigm’s (MDRX) 50-Day exponential moving average is 10.04, while Veradigm’s (MDRX) share price is $9.5, making it a Sell.

Veradigm (MDRX) Pivot Points

Dec 22, 2024, 05:57 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.01
9.25
9.38
9.63
9.76
10.00
10.13
Fibonacci
9.25
9.40
9.49
9.63
9.77
9.86
10.00
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Veradigm (MDRX) Moving Averages

Dec 22, 2024, 05:57 AM
Period
Simple
Exponential
MA5
9.60Sell
9.66Sell
MA10
9.99Sell
9.89Sell
MA20
10.29Sell
10.09Sell
MA50
9.97Sell
10.04Sell
MA100
9.78Sell
9.82Sell
MA200
9.19Buy
9.36Buy
Veradigm’s (MDRX) 10-Day exponential moving average is 9.89, while Veradigm’s (MDRX) share price is $9.5, making it a Sell.
Veradigm’s (MDRX) 100-Day exponential moving average is 9.82, while Veradigm’s (MDRX) share price is $9.5, making it a Sell.
Veradigm’s (MDRX) stock price is $9.5 and Veradigm’s (MDRX) 50-day simple moving average is 9.97, creating a Sell signal.
Veradigm’s (MDRX) stock price is $9.5 and Veradigm’s (MDRX) 100-day simple moving average is 9.78, creating a Sell signal.
Veradigm’s (MDRX) stock price is $9.5 and Veradigm’s (MDRX) 200-day simple moving average is 9.19, creating a Buy signal.

Veradigm (MDRX) Technical Indicators

Dec 22, 2024, 05:57 AM
Name
Value
Implied Action
RSI (14)
39.56
Neutral
STOCH (9,6)
30.52
Neutral
STOCHRSI (14)
20.95
Neutral
MACD (12,26)
-0.16
Buy
ADX (14)
26.74
Neutral
Williams %R
-82.14
Buy
CCI (14)
-139.03
Buy
ATR (14)
0.55
-
Ultimate Oscillator
38.60
Neutral
ROC
-5.47
Sell
Veradigm’s (MDRX) Relative Strength Index (RSI) is 39.56, creating a Neutral signal.
Veradigm’s (MDRX) Trend Strength Indicator (ADX) is 26.74, creating a Neutral signal.
Veradigm’s (MDRX) Commodity Channel Index (CCI) is -139.03, creating a Buy signal.
Veradigm’s (MDRX) Price Rate of Change (ROC) is -5.47, creating a Sell signal.

FAQ

Is MDRX a Buy, Hold, or Sell?
Based on MDRX’s technical indicators, MDRX is a Sell.
    What is MDRX’s RSI (14)?
    MDRX’s RSI (14) is 39.56, which suggests MDRX is a Neutral.
      What is MDRX’s MACD?
      MDRX’s MACD is -0.16, which suggests MDRX is a Buy.
        What is MDRX’s 5-day moving average?
        MDRX’s 5-day moving average is 9.60, which suggests MDRX is a Sell.
          What is MDRX’s 20-day moving average?
          MDRX 20-day moving average is 10.29, which suggests MDRX is a Sell.
            What is MDRX’s 50-day moving average?
            MDRX’s 50-day moving average is 9.97, which suggests MDRX is a Sell.
              What is MDRX’s 200-day moving average?
              MDRX’s 200-day moving average is 9.19, which suggests MDRX is a Buy.
                What is MDRX’s Williams % R (14)?
                MDRX’s Williams % R (14) is -82.14, which suggests MDRX is a Buy.
                  What is MDRX’s CCI (14)?
                  MDRX’s CCI (14) is -139.03, which suggests MDRX is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis